Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre

References

• Azim AA, Costantini-Ferrando M, Oktay K. 2008. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. Journal of Clinical Oncology 26:2630–2635.
   PubMed Web of Science ®Google Scholar
• Bedoschi G, Navarro PA, Oktay K. 2016. Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncology 12:2333–2344.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 68:394–424.
   PubMed Web of Science ®Google Scholar
• Brenner DR, Ruan Y, Shaw E, O’Sullivan D, Poirier AE, Heer E, et al. 2019. Age-standardized cancer-incidence trends in Canada, 1971–2015. Canadian Medical Association Journal 191:E1262–E1273.
   Web of Science ®Google Scholar
• Cakmak H, Katz A, Cedars MI, Rosen MP. 2013. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertility and Sterility 100:1673–1680.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. 2019. Breast cancer statistics, 2019. CA: A Cancer Journal for Clinicians 69:438–451.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Lambertini M, Macklon KT, Almeida ST, Ruiz-Casado A, Borini A, et al. 2019. EUropean REcommendations for female FERtility preservation (EU-REFER): a joint collaboration between oncologists and fertility specialists. Critical Reviews in Oncology/Hematology 138:233–240.
   PubMed Web of Science ®Google Scholar
• Dunn L, Fox KR. 2009. Techniques for fertility preservation in patients with breast cancer. Current Opinion in Obstetrics and Gynecology 21:68–73.
   PubMed Web of Science ®Google Scholar
• Ethics Committee of the American Society for Reproductive Medicine 2018. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertility and Sterility 110:380–386.
   PubMed Web of Science ®Google Scholar
• Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH. 2014. Fertility after breast cancer treatment. European Journal of Obstetrics and Gynecology and Reproductive Biology 173:13–18.
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim SK, Lee HJ, Lee JR, Jee BC, Suh CS, et al. 2015. Efficacy of random-start controlled ovarian stimulation in cancer patients. Journal of Korean Medical Science 30:290–295.
   PubMed Web of Science ®Google Scholar
• Kim J, Turan V, Oktay K. 2016. Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer. The Journal of Clinical Endocrinology and Metabolism 101:1364–1371.
   PubMed Web of Science ®Google Scholar
• Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, et al. 2019. Breast cancer in young women: status quo and advanced disease management by a predictive, preventive, and personalized approach. Cancers 11:1791.
   PubMed Web of Science ®Google Scholar
• Letourneau JM, Wald K, Sinha N, Juarez-Hernandez F, Harris E, Cedars MI, et al. 2020. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation. Cancer 126:487–495.
   PubMed Web of Science ®Google Scholar
• Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, et al. 2013. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology 31:2500–2510.
   PubMed Web of Science ®Google Scholar
• Meirow D, Nugent D. 2001. The effects of radiotherapy and chemotherapy on female reproduction. Human Reproduction Update 7:535–543.
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, Akar M, Rosenwaks Z. 2005. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Journal of Clinical Oncology 23:4347–4353.
   PubMed Web of Science ®Google Scholar
• Oktay K, Hourvitz A, Sahin G, Oktem O, Safro B, Cil A, et al. 2006. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. The Journal of Clinical Endocrinology and Metabolism 91:3885–3890.
   PubMed Web of Science ®Google Scholar
• Peccatori FA, Azim HA, Jr, Orecchia R, Hoekstra HJ, Pavlidis N, Kesic V, et al. 2013. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 24:vi160–70.
   PubMed Web of Science ®Google Scholar
• Reynolds KA, Grindler NM, Rhee JS, Cooper AR, Ratts VS, Carson KR, et al. 2015. Variability in the practice of fertility preservation for patients with cancer. PLOS One 10:e0127335.
   PubMed Web of Science ®Google Scholar
• Rodgers RJ, Reid GD, Koch J, Deans R, Ledger WL, Friedlander M, et al. 2017. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review. Human Reproduction 32:1033–1045.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Wallberg KA, Oktay K. 2010. Fertility preservation in women with breast cancer. Clinical Obstetrics and Gynecology 53:753–762.
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. 2006. Fertility preservation in young women undergoing breast cancer therapy. The Oncologist 11:422–434.
   PubMed Web of Science ®Google Scholar
• Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. 2019. Ovarian damage from chemotherapy and current approaches to its protection. Human Reproduction Update 25:673–693.
   PubMed Web of Science ®Google Scholar
• Ter Welle-Butalid M, Vriens I, Derhaag J, Leter E, de Die-Smulders C, Smidt MM, et al. 2019. Counseling young women with early breast cancer on fertility preservation. Journal of Assisted Reproduction and Genetics 36:2593–2604.
   PubMed Web of Science ®Google Scholar
• von Wolff M, Thaler CJ, Frambach T, Zeeb C, Lawrenz B, Popovici RM, et al. 2009. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertility and Sterility 92:1360–1365.
   PubMed Web of Science ®Google Scholar